---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-090120"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2024-10-24T23:59:59+00:00"
generated_at: "2026-05-30T10:33:39.258888+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics shareholders approve reverse stock split (1:20-1:50 ratio)

## Summary
- 6,958,210 shares present (42.0% quorum) at October 23, 2024 special meeting.
- Proposal passed: 5,358,166 For, 1,487,443 Against, 112,601 Abstain.
- Board retains discretion to select exact ratio (1:20 to 1:50) and timing.
- No decision yet on whether or when to implement the reverse stock split.

## SEC filing metadata
- accession: 0001213900-24-090120
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2024-10-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390024090120/0001213900-24-090120-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390024090120/ea0218491-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-090120
- JSON: https://secwatch.observer/filing/0001213900-24-090120.json
- Plain text: https://secwatch.observer/filing/0001213900-24-090120.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.